Peptide and Protein Drug Delivery Specialists are experts focused on developing advanced systems to optimize the delivery of biologic drugs, including peptides and proteins, to patients. Due to the inherent challenges of these molecules, such as their large size, instability, and poor permeability through biological membranes, they require specialized delivery techniques. These specialists use cutting-edge technologies like nanoparticles, liposomes, and polymer-based carriers to enhance the stability, bioavailability, and targeted delivery of peptides and proteins. Their goal is to ensure that these therapeutic proteins reach the desired target site effectively while minimizing side effects and avoiding degradation in the body.
These professionals work closely with multidisciplinary teams to design and improve drug formulations aimed at treating complex diseases such as cancer, diabetes, and autoimmune disorders. They focus on optimizing the pharmacokinetics of peptides and proteins, including enhancing their half-life and ensuring controlled release. By developing innovative delivery methods, these specialists not only improve the effectiveness of biologic therapies but also reduce the need for frequent dosing. Their expertise in overcoming biological barriers helps maximize the therapeutic potential of these treatments. Through their work, peptide and protein drug delivery specialists play a crucial role in advancing the treatment landscape, offering patients more precise, efficient, and personalized care.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia